Efficacy of a CDK4/6 Inhibitor in a Patient with Breast Cancer and Liposarcoma: A Case Report and Review of the Literature.

Loretan, Laura; Moskovszky, Linda Eszter; Kurrer, Michael; Exner, G Ulrich; Trojan, Andreas

Loretan, Laura; Moskovszky, Linda Eszter; Kurrer, Michael; Exner, G Ulrich; Trojan, Andreas.

Afiliação

Loretan L; Brust-Zentrum Zürich, Zürich, Switzerland.
Moskovszky LE; Institut für klinische Pathologie, Universitätsspital Zürich, Zürich, Switzerland.
Kurrer M; Gemeinschaftspraxis Pathologie Zürich, Zürich, Switzerland.
Exner GU; Orthopädie Zentrum Zürich, Zürich, Switzerland.
Trojan A; OnkoZentrum Zürich, Zürich, Switzerland.

Breast Care (Basel) ; 14(5): 325-328, 2019 Oct.

Article em En | MEDLINE | ID: mdl-31798393

Palavras-chave

Aromatase inhibitors; Biomarker; Breast cancer; CDK4/6 inhibitor; Drug resistance; Endocrine therapy; HER2 / HER2/neu; Hormonal treatment; Liposarcoma; Palbociclib

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Breast Care (Basel) Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google